Bausch + Lomb Corporation (BLCO) Price Target Analysis
Updated Jun 18, 2026
Analyst Rating: Hold
Based on 16 analysts24.9% Below Target
BLCO trades 24.9% below Wall Street's consensus target of $18.57.
Current Price$14.87
Average Target$18.57
Target
Current
Low$16.00
Median$19.00
High$21.00
Analyst Target Range
Forward P/E18.4x
(Fair)
PEG Ratio—
Implied Growth+230.7%
(High Growth)
Analyst Spread26.9%
(High Agreement)
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Consensus Scenario Assumptions
The base valuation assumes BLCO achieves its forward estimates and maintains a stable P/E multiple of 18.4x. This scenario reflects the blended consensus of 16 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
BLCO Price Target Analysis
Updated June 21, 2026As of June 21, 2026, Bausch + Lomb Corporation (BLCO) has a Wall Street consensus price target of $18.57, based on estimates from 16 covering analysts. With the stock currently trading at $14.87, this represents a potential upside of +24.9%. The company has a market capitalization of $5.30B.
Analyst price targets range from a low of $16.00 to a high of $21.00, representing a 27% spread in expectations. The median target of $19.00 aligns closely with the consensus average.
The current analyst consensus rating is Hold, with 7 analysts rating the stock as a Buy or Strong Buy,8 rating it Hold, and 1 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, BLCO trades at a trailing P/E of -14.6x and forward P/E of 18.4x. Analysts expect EPS to grow +230.7% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside
+25.7%
Industry Consensus
Avg Forward P/E
89.4x
(High Premium)
Peers with Coverage
10 / 10
Active Analyst Tracking
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 HSICHenry Schein, Inc. | $9.2B | $79.92 | $87.43 | +9.4% | Buy | 14.9x | 33 |
 ATRCAtriCure, Inc. | $1.5B | $28.80 | $51.33 | +78.2% | Buy | 768.0x | 19 |
 LNTHLantheus Holdings, Inc. | $6.8B | $103.86 | $108.50 | +4.5% | Buy | 19.4x | 17 |
 JNJJohnson & Johnson | $550.4B | $228.39 | $251.55 | +10.1% | Buy | 19.7x | 40 |
 ABTAbbott Laboratories | $153.7B | $88.38 | $127.46 | +44.2% | Buy | 16.1x | 41 |
 COOThe Cooper Companies, Inc. | $12.9B | $65.91 | $80.33 | +21.9% | Buy | 14.2x | 25 |
 HOLXHologic, Inc. | $17.0B | $76.01 | $78.69 | +3.5% | Hold | 17.2x | 42 |
 IARTIntegra LifeSciences Holdings Corporation | $1.4B | $17.58 | $18.50 | +5.2% | Buy | 7.2x | 26 |
 ALGNAlign Technology, Inc. | $13.0B | $182.08 | $203.60 | +11.8% | Buy | 16.0x | 33 |
 BHCBausch Health Companies Inc. | $1.8B | $4.77 | $8.00 | +67.7% | Buy | 1.1x | 38 |
BLCO — Frequently Asked Questions
Quick answers to the most common questions about buying BLCO stock.
What is the BLCO stock price target for 2026?
The consensus Wall Street price target for BLCO is $18.57, representing 24.9% upside from the current price of $14.87. With 16 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is BLCO a buy, sell, or hold?
BLCO has a consensus rating of "Hold" based on 16 Wall Street analysts. The rating breakdown is mixed, with 8 Hold ratings making up the largest segment. The consensus 12-month price target of $18.57 implies 24.9% upside from current levels.
Is BLCO stock overvalued or undervalued?
With a forward P/E of 18.4491x, BLCO trades at a relatively low valuation. The consensus target of $18.57 implies 24.9% appreciation, suggesting meaningful undervaluation.
How high can BLCO stock go?
The most bullish Wall Street analyst has a price target of $21 for BLCO, while the most conservative target is $16. The consensus of $18.57 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover BLCO stock?
BLCO is well covered by analysts, with 16 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 7 have Buy ratings, 8 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the BLCO stock forecast?
The 12-month BLCO stock forecast based on 16 Wall Street analysts shows a consensus price target of $18.57, with estimates ranging from $16 (bear case) to $21 (bull case). The median consensus rating is "Hold".
What is BLCO's forward P/E ratio?
BLCO trades at a forward P/E ratio of 18.4x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy BLCO stock?
Wall Street analysts are very optimistic on BLCO, with a "Hold" consensus rating and $18.57 price target (24.9% upside). 7 of 16 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do BLCO price targets vary so much?
BLCO analyst price targets range from $16 to $21, a 27% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $18.57 consensus represents the middle ground.
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare